Alexandros Papachristofilou
Alexandros Papachristofilou, MD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,⁎,
Tobias Finazzi
Tobias Finazzi, MD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Andrea Blum
Andrea Blum, MD
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
b,
Tatjana Zehnder
Tatjana Zehnder, MD
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
b,
Núria Zellweger
Núria Zellweger
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
b,
Jens Lustenberger
Jens Lustenberger, MD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Tristan Bauer
Tristan Bauer, MD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Christian Dott
Christian Dott
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Yasar Avcu
Yasar Avcu
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Götz Kohler
Götz Kohler, PhD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Frank Zimmermann
Frank Zimmermann, MD
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
a,
Hans Pargger
Hans Pargger, MD
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
b,
Martin Siegemund
Martin Siegemund, MD
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
b
aClinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
bClinic of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
⁎Corresponding author. Clinic of Radiotherapy and Radiation Oncology. University Hospital Basel. Petersgraben 4, 4031 Basel, Switzerland. Phone: +41612654946.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.